Literature DB >> 6696825

A chlorambucil-anti-CEA conjugate cytotoxic for human colon adenocarcinoma cells in vitro.

L G Bernier, M Page, R C Gaudreault, L P Joly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6696825      PMCID： PMC1976705          DOI： 10.1038/bjc.1984.38

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  Binding of chlorambucil with antitumor globulins and its effect on drug and antibody activities.

Authors:  A Guclu; T Ghose; J Tai; M Mammen
Journal:  Eur J Cancer       Date:  1976-02       Impact factor: 9.162

2.  Factors affecting the noncovalent binding of chlorambucil to rabbit immunoglobulin G.

Authors:  D Blakeslee; J C Kennedy
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

3.  Tumor inhibition by chlorambucil covalently linked to antitumor globulin.

Authors:  J Tai; A H Blair; T Ghose
Journal:  Eur J Cancer       Date:  1979-11       Impact factor: 9.162

4.  Anti-oncofoetal proteins for targeting cytotoxic drugs.

Authors:  M Belles-Isles; M Pagé
Journal:  Int J Immunopharmacol       Date:  1981

5.  Aggregation of chlorambucil in vitro may cause misinterpretation of protein binding data.

Authors:  D Blakeslee; M Chen; J C Kennedy
Journal:  Br J Cancer       Date:  1975-06       Impact factor: 7.640

6.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307
  6 in total
  1 in total

1.  Peptides and proteins as drugs.

Authors:  B L Ferraiolo; L Z Benet
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.